Telephone: +41 22 884 15          +44 (0)20 7318 2955           (646)-755-7412 
 55                                mailto:msinclair@halsin.com   james@haydenir.com 
 mailto:PR@addextherapeutics.com   msinclair@halsin.com 
 PR@addextherapeutics.com 
--------------------------------  ---------------------------- 
 
   Forward Looking Statements: 
 
   This press release contains forward-looking statements within the 
meaning of the Private Securities Litigation Reform Act of 1995, as 
amended, including in respect of the anticipated initiation of clinical 
trials. The words "may," "will," "could," "would," "should," "expect," 
"plan," "anticipate," "intend," "believe," "estimate," "predict," 
"project," "potential," "continue," "target" and similar expressions are 
intended to identify forward-looking statements, although not all 
forward-looking statements contain these identifying words. Any 
forward-looking statements in this press release, are based on 
management's current expectations and beliefs and are subject to a 
number of risks, uncertainties and important factors that may cause 
actual events or results to differ materially from those expressed or 
implied by any forward-looking statements contained in this press 
release, including, without limitation, uncertainties related to market 
conditions. These and other risks and uncertainties are described in 
greater detail in the section entitled "Risk Factors" in Addex 
Therapeutics' Annual Report on Form 20-F for the year ended December 31, 
2019, as filed with the SEC on April 27, 2020, the prospectus related to 
the global offering and other filings that Addex Therapeutics may make 
with the SEC in the future. Any forward-looking statements contained in 
this press release represent Addex Therapeutics' views only as of the 
date hereof and should not be relied upon as representing its views as 
of any subsequent date. Addex Therapeutics explicitly disclaims any 
obligation to update any forward-looking statements.

(END) Dow Jones Newswires

March 11, 2021 01:00 ET (06:00 GMT)